Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 FY- Text added to 2016 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
abroad, altering, anniversary, anticancer, antigen, antitumor, APC, apprised, aspect, attack, Biomarin, Biomedical, Boston, BRAF, bring, bystander, camera, cascade, CCTG, checkpoint, chemo, chemotactic, cliff, coincident, compelling, complementary, constant, CrytpoMedix, deleted, dendritic, display, displayed, dysfunctional, effector, EGFR, endpoint, EU, European, FAAN, facilitate, female, gene, Gutierrez, heavily, IMiD, immunogenic, immunological, immunotherapy, indeterminate, infiltration, inflamed, inflammatory, inhibitor, inlcuding, innate, instance, interdependent, intratumoral, ITu, JNK, killer, liver, LLD, Matt, melanoma, merit, Mexico, microenvironment, milieu, minimal, modulator, mononuclear, MTD, Neuro, NK, NY, oncogenic, oncologist, Oxford, peak, peaked, pelareorep, permissive, PhD, phenotype, prognostic, progression, progressively, proinflammatory, prolong, promptly, Proteolix, radiotherapy, randomized, Rb, relief, REO, REOLSYIN, revealed, rituximab, Rochester, Science, sensitivity, show, showed, Simultaneously, solid, Steele, suggest, suit, suppressor, survival, thereunder, Tolerated, toxic, tumor, twelve, Union, unmodified, USD, vacancy, Wayne
Removed:
aberrant, accumulate, actuarial, Acuity, adjuvant, amalgamation, Amersfoort, Antonio, asymptomatic, attempt, attractive, August, Avastin, Bevacizumab, blocking, brain, break, breast, capable, capitalization, Caputo, carboplatin, central, CFO, chart, clarification, competent, COO, Cowen, created, crucial, CTRC, cycle, Cyclophosphamide, deem, deficient, deteriorate, deterioration, differentiation, disrupt, Docetaxel, double, element, ensue, epidermal, etiology, eventually, exacerbated, expanded, Export, fact, fifty, foreclosed, freely, functionality, gastrointestinal, gemcitabine, generation, grow, half, impair, impinge, implanted, importantly, infect, injection, introducing, lacking, Lane, leukemia, lie, liquidating, maximize, mice, mild, mind, mitogenic, molecular, monotherapy, mouse, multiplied, mutation, myeloid, naturally, NCIC, nil, ninetieth, noted, organ, Outlook, Ovarian, paclitaxel, page, participated, PDGFR, Pemetrexed, play, pool, possessing, premise, progeny, proliferative, prostate, radiation, rare, receptor, Recurrent, regression, regulator, relayed, repeated, replicate, respiratory, retired, Robert, Rockwater, San, schematic, signaling, split, sponsor, sporadic, spread, STB, stimulating, stimuli, stranded, subset, sum, target, thereon, thought, thwart, tissue, tract, TransAlta, transduction, transmission, travel, tyrosine, uncontrolled, unqualified, van, warranted, Western, wholesale, yielded
Valuein 2015 FY filing- Value in 2016 FY filing
Original filings
Filing view